Programmed cell death of peripheral myeloid precursor cells in Down patients: Effect of zinc therapy

Ultrastructural Pathology

Volumn 20, Issue 5, 1996, Pages 457-462

  Trubiani, Oriana ^a   Antonucci, Adriano ^a   Palka, Giandomenico ^a   Di Primio, Roberto ^b  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Apoptosis; Differentiation; Down syndrome; Zinc

Indexed keywords

ZINC SULFATE;

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; CHILD; CLINICAL ARTICLE; DOWN SYNDROME; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; INFANT; MALE; PRIORITY JOURNAL; ULTRASTRUCTURE;

EID: 0029783191     PISSN: 01913123     EISSN: None     Source Type: Journal    
DOI: 10.3109/01913129609016349     Document Type: Article

References (34)

1. Lejeune J. Le mongolisme, premier example d'aberration autosomique humane. Ann Gènét. 1959;1:141-149.
2. Ibarra B, Rivas F, Medina C, et al. Hematological and biochemical studies in children with Down syndrome. Ann Genet. 1990;33:84-87.
3. Lejeune J. Pathogénie de la débilité de l'intelligence dans la Trisomie 21. Ann Génét. 1991;34:55-64.
4. Karttunen R, Nurmi T, Ilonen J, Surgel HM. Cell-mediated immunodeficiency in Down's syndrome: normal interleukine-2 production but inverted ratio of T cell subsets. Clin Exp Immunol. 1984;55:257-263.
5. Noble RL, Warren RP. Altered T-cell subsets and defective T-cell function in young children with Down syndrome (Trisomy 21). Immunol Invest. 1987;16:371-382.
6. Cossarizza A, Monti D, Montagnani G, et al. Precocious aging of the immune system in Down syndrome: alteration of B lymphocytes, T lymphocyte subsets and cells with natural killer markers. Am J Med Genet Suppl. 1990; 7:213-218.
7. Licastro F, Zannotti M, Davis LJ, et al. Restoration of superoxide generation from activated granulocytes in children with Down's syndrome by zinc supplementation: clinical and immunological one-year follow up. Fundam Clin Immunol. 1993;1:17-21.
8. Djaldetti M, Bessler H, Fisman P, Van Der Lyn E, Joshua H. Ultrastructural features of the granulocytes in Down's syndrome. Scand J Haematol. 1974;12:104-111.
9. Mills EL, Quie PG. Congenital disorders of the functions of polymorphonuclear neutrophils. Rev Infect Dis. 1980;2: 505-510.
10. Fraker PJ, Gershwin ME, Good RA, Prasad A. Interrelationships between zinc and immune function. In Summary of Symposium of 69th Annual Meeting of the Federation of American Societies for Experimental Biology, Anaheim, California; 1985;1474-1479.
11. Fredricks RE, Tanaka KR, Valentine WN. Variation of human blood cell zinc in disease. J Clin Invest. 1964;43:304-315.
12. Prasad AS, Meftah S, Abdallah J, et al. Serum thymulin in human zinc deficiency. J Clin Invest. 1988;82:1202-1210.
13. Allen JI, Perri RT, McClain CJ, Kay NE. Alterations in human natural killer cell activity and monocyte cytotoxicity induced by zinc deficiency. J Lab Clin Med. 1985;102:577-589.
14. Keen C, Gershwin ME. Zinc deficiency and immune function. Annu Rev Nutr. 1990;10:415-427.
15. Wirth JJ, Fraker PJ, Kierszenbaum F. Zinc requirement for macrophage function: effect of zinc deficiency on uptake and killing of a protozoan parasite. Immunology. 1989;68: 114-119.
16. Bjorksten B, Back O, Gustavson KH, Hallmans G, Hagglof B, Tarnvik A. Zinc and immune function in Down's syndrome. Acta Paediatr Scand. 1980;69:183-187.
17. Vruwink KG, Fletcher MP, Keen CL, Golub MS, Hendrick AG, Gershwin ME. Moderate zinc deficiency in rhesus monkeys: an intrinsic defect of neutrophil chemotaxis correct by zinc repletion. J Immunol 1991;146:244-247.
18. Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol. 1980;68:251-305.
19. Ellis RE, Yuan J, Hortviz HR. Mechanisms and functions of cell death. Ann Rev Cell Biol. 1991;7:663-698.
20. Gerschenson LE, Rotello RJ. Apoptosis: a different type of cell death. FASEB J. 1992;6:2450-2455.
21. Linette GP, Korsmeyer SJ. Differentiation and cell death: lesson from the immune system. Curr Opin Biol. 1994;6: 809-815.
22. Arends MJ, Morris RG, Wyllie AH. Apoptosis: the role of the endonuclease. Am J Pathol. 1990;136:593-697.
23. Cohen JJ, Duke RC. Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. J Immunol. 1984;132:38-42.
24. 2+ concentration. Arch Biochem Biophys. 1989;299:365-370.
25. Iseki R, Mukai M, Iwata M. Regulation of T lymphocyte apoptosis: signal for the antagonism between activation and glucocorticoid-induced death. J Immunol. 1991;147: 4286-4292.
26. Prasad AS. Discovery and importance of zinc in human nutrition. Fed Proc. 1984;43:2829-2834.
27. Zalewski PD, Forbes IJ, Giannakis C. Physiologic role for zinc in prevention of apoptosis (gene-direct death). Biochem Int. 1991;24:1093-1101.
28. Barbieri D, Troiano L, Grassilli E, et al. Inhibition of apoptosis by zinc: a reappraisal. Biochem Biophys Res Commun. 1992;187:1256-1261.
29. De La Torre J, Sumner AT, Gosalvez J, Stuppia L. The distribution of genes on human chromosomes as studied by in situ nick translation. Genome. 1992;35:890-893.
30. D'Andrea AD. Hematopoietic growth factors and the regulation of differentiative decisions. Curr Opin Biol. 1994;6: 804-808.
31. Yoshida Y. Hypothesis: apoptosis may be the mechanism responsible for the premature intramedullary cell death in the myelodysplastic syndrome. Leukemia. 1993;7:144-146.
32. Dexter TM, Spooncer E. Growth and differentiation in the hemopoietic system. Annu Rev Cell Biol. 1987;7:423-441.
33. Migliorati G, Pagliacci C, Moraca R, Crocicchio F, Nicoletti I, Riccardi C. Interleukins modulate glucocorticoid-induced thymocyte apoptosis. Int J Clin Lab Res. 1992;21:300-303.
34. Fairbairin LJ, Cowling GJ, Reipert BM, Dexter TM. Suppression of apoptosis allow differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors. Cell. 1993;74:823-832.